Biotech China 2014

Cancer Biology: Merck

Total Score People Score Events Score
98 81 69
Date Event Presentation Speakers
February 11, 2014 Jagelman/Turnbull International Colorectal Disease Symposium Management of dysplasia in mucosal ulcerative colitis R Phillips
March 19, 2013 World CDx Frankfurt Bridging research & clinical care: Translating biomarker & diagnostic tools into patient treatment Alain van Gool
December 4, 2012 CGS – The Cancer Genome Summit How is Sequencing Technology Evolving and What Does This Mean for the Future of Drug Development? J Watters
May 23, 2012 Biomarkers World Europe 2012 stream two | Biomarkers in early stage CNS clinical development Mary Savage
Keeping the promise: Pathway-based identification of patient stratification and proof of mechanisms for targeted kinase therapeutics Cloud Paweletz
February 20, 2012 Advances and Progress in Drug Design Noticing the unnoticed: bridging structural data and drug design Jose Duca
Biophysics in drug discovery: integrative use of structural, kinetic and thermodynamic data Matthias Frech
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Path to clinical development of Anticalins and other new scaffolds Laurent Audoly
June 20, 2011 Changing Landscape of the Cancer Genome (F3) Bridging the Gap between Cancer Genomics and Drug Discovery Giulio F Draetta
March 23, 2011 Accelerating Patient Recruitment & Retention in Clinical Trials Using new media for patient recruitment Natalie Dewberry-Moore
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer Clinical development of MK-2206: A potent oral allosteric AKT inhibitor Li Yan
January 31, 2011 Biomarkers Summit STREAM ONE | USE OF PROTEOMICS TO DISCOVER CELL SURFACE MARKERS OF APOPTOSIS Huseyin Mehmet
TRANSLATIONAL BIOMARKERS IN THE DEVELOPMENT OF NOVEL ANALGESIC DRUGS Ge Ruigt
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Preclinical Development of RNA Therapeutics Michael Flanagan
microRNA mimics and diagnostics Lee P. Lim
August 25, 2010 Co-Development of Drugs and Diagnostics Choosing a Biomarker Partner Cynthia Gawron-Burke
August 18, 2010 Challenges in Pre-Clinical & Clinical Development - Top 5 Challenges in Vaccines & Immunotherapeutics Development of Biomarkers of Vaccine Efficacy Against Chronic Viral Infections Danilo Casimiro,
IDENTIFYING BIOMARKERS FOR IMMUNE RESPONSE Danilo Casimiro,
Strategies for the Non-Clinical Safety Assessment of Vaccines Jayanthi Wolf
August 17, 2010 Production & Manufacturing of Vaccines After the License Approval - What Can Analytics Do? Robert D. Sitrin
July 11, 2010 Translational Cancer Medicine 2010 (USA) The biomarker roadmap: How to integrate biomarker and compound discovery for early clinical decision making Pearl S. Huang
Why current ways of working together as patients, clinicians, and scientists could ultimately fail Stephen H Friend
June 23, 2010 Structure-Based Drug Design TABLE 4: Do We Get the Most Out of the Structural information in the PDB? Tips and Lessons Learned José Duca
Chairperson’s Remarks José Duca
May 19, 2010 Towards Personalized Cancer Medicine Integrative Genomic Models of Disease, Use of Contributor Networks Stephen H Friend
SESSION IV: Biomarkers for Prognosis/Response: Impact on Clinical Trials Stephen H Friend
Molecular Profiling of Pre-Clinical and Clinical Models: Informing the Development of Rational Combinations James Watters
PANEL DISCUSSION Stephen H Friend
May 4, 2010 Biomarker World Congress 2010 Identification of a Transcriptional Biomarker of Target Engagement and Use in Oncology Early Clinical Development Samuel C. Blackman
Practice and Pitfalls of Open Source Precompetitive Collaboration on Biomarkers John A. Wagner
From Biomarker Strategies to Biomarker Activities and Back Alain van Gool
April 30, 2010 Drug Story Dll4 and Notch1 Antagonist Antibodies Inhibit Yan Wu
April 28, 2010 Kinase Inhibitor Chemistry Featured Presentation Discovery of Novel Kinase Inhibitors Using Structure-Based Design Jose Duca
November 6, 2009 Clinical Applications for Age Management Medicine Continental Breakfast Martin D. Leach
October 13, 2009 Fourth Annual Drug Repositioning Summit Knowledge Management Technologies for Drug Repurposing Natalia Novac
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Strategies for a Competitive Biologics Portfolio Georg Feger
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Case Presentation 3: Second-Line and Third-Line Brendan O’Neill
Session 3: Advanced Colorectal Cancer Brendan O’Neill
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Proteomics - From Basic Research to the Clinic Ronald C. Hendrickson
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Missing Data Mechanisms in a Dose Finding Adaptive Trial Kenneth Liu
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis IT Frameworks for Supporting Analysis of Complex Data Sets in Translational Medicine Research Gary K. Mallow
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Risk Management in Vaccine Development Programs Adrian Dana
August 17, 2009 Fourth Annual Novel Vaccines: Design & Development Plenary Featured Presentation Risk-Based Modelling for Vaccine Supply Chain Capacity Assessment Susan Behrens
August 17, 2009 Inaugural Production & Manufacturing of Vaccines Risk-Based Modelling for Vaccine Supply Chain Capacity Assessment Susan Behrens
August 10, 2009 Second Annual Trends in Cancer Diagnostics Cancer Biomarkers to Predict Therapeutic Response Cynthia Gawron-Burke
August 5, 2009 Drug Safety Strategies to De-Risk Compounds An in vitro and in vivo Evaluation of the Off-Target Profile of the CETP Inhibitor, Torcetrapib Michael J. Forest
August 3, 2009 Oligonucleotide Therapeutics - From Concept to Implementation Agenda RNA Therapeutics - Are We Leveraging on the Promise? Paul Burke
June 9, 2009 Genomic Sample Prep Development of a Microarray Platform for FFPET Profiling: Application to the Classification of Human Tumors Mingjie Zhou
June 9, 2009 RNAi for Target Identification and Validation A High-Throughput Chemical Biology Approach to Identify Modulators of the Hypoxia Inducible Factor (HIF) Pathway Marc Ferrer
June 9, 2009 Cell and Tissue-Based Assays for HTS Data Analysis in RNAi High-Throughput Screens Xiaohua Douglas Zhang
Evaluation of Putative GPCR Antagonists Using the CellKey System David J. Bell, Department of Automated Biotechnology, Merck & Company David J. Bell
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Inward Rectifier Kir2.1 PatchXpress Assay as a Model of Cardiac IK1 John P. Imredy
June 8, 2009 RNAi for Functional Screens OPTIMIZING RNAi DELIVERY FOR IN VITRO APPLICATIONS Shane Marine
June 8, 2009 Tackling RNAi Delivery OPTIMIZING RNAi DELIVERY FOR IN VITRO APPLICATIONS Shane Marine
June 1, 2009 Combination Products Regulatory Strategy for Combination Products Chitkala Kalidas
April 7, 2009 Inaugural HIV Inhibitors KEYNOTE PRESENTATION: The Discovery of Novel HIV Integrase Inhibitors Joseph P. Vacca
KEYNOTE PRESENTATION: The Discovery of Novel HIV Integrase Inhibitors Joseph P. Vacca
March 9, 2009 Drug Development Latin America Organizer’s Welcome and Chairperson’s Remarks Jorge Rodriguez Larrain
Chairperson’s Remarks Jorge Rodriguez Larrain
Adaptative Designs (Phase I - III): Regulatory Challenges and Opportunities in Latin America Jorge Rodriguez Larrain
December 2, 2008 Vaccines Europe 1: Potential correlates of protection and immune monitoring for prophylactic vaccines against chronic viral infections Danilo Casimiro,
December 1, 2008 European Antibody Congress 2008 Engineering differentiating pharmacology in monoclonal antibodies using protein- and glycoengineering Laurent Audoly
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics New(er) Tools for Rapid Metabolite Identification Kevin Bateman
Minimizing Drug Toxicities During Drug Discovery and Development | Altas Ballroom (Town & Country/San Diego) Tom Baillie
Unusual Interspecies Differences in the Metabolism of a Cathepsin K Inhibitor Deborah Nicoll-Griffith
Unusual Interspecies Differences in the Metabolism of a Cathepsin K Inhibitor Deborah Nicoll-Griffith
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Decision-Making in Oncology Drug Development Stephen H Friend
Panel Discussion Stephen H Friend
April 27, 2008 Phage Display of Antibodies and Peptides Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
March 25, 2008 Mastering Medicinal Chemistry Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists for the Treatment of Migraine: Challenges in the Development of Clinical Candidate MK-0974 Christopher Steven Burgey
Histone Deacetylase Inhibitors: Bench to Bedside Thomas A. Miller
Discovery of Novel DPP-4 Inhibitors Tesfaye Biftu
Discovery of Taranabant, a Novel CB1R Inverse Agonist for the Treatment of Obesity Linus S Lin
March 25, 2008 PATHWAY ANALYSIS Innovative Medicines for Europe Phil Hewitt
March 25, 2008 THE STEM CELLS CONGRESS Chairperson’s Remarks Huseyin Mehmet
March 25, 2008 CANCER MOLECULAR MARKERS Chairperson’s Remarks Huseyin Mehmet
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Applications of Molecular Profiling to RNA Therapeutics Aimee L Jackson
February 19, 2008 Screening Europe Track A Neglected Diseases: Building a Lead Discovery Engine Dominique Perrin
February 19, 2008 MedChem Europe HDAC Inhibitors: Bench to Bedside Thomas A. Miller
December 4, 2007 7th World Drug Discovery & Development Summit 2007 Conference room 2 PREDICTIVE TOXICITY SCREENING PRIOR TO DEVELOPMENT Dr. Stefan Otto Mueller
Conference room 2 HIGH CONTENT SCREENING Jinghai Xu
November 29, 2007 Fourth Annual In Vivo Molecular Imaging: Bridging the Gap from Discovery to Clinical Applications Nov (29-30) Pre-Clinical Imaging (08:25-12:15) John Atack
Pre-Clinical Imaging: PET Imaging and Occupancy Measurements in Rat, Monkey and Humans (08:30-09:00) John Atack
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Assessing Structure/Function Relationships (08:15-10:45) Michael W. Washabaugh
Assessing Structure/Function Relationships :Assessing Product Potency & Related Characteristics of Gardasil,® a Recombinant HPV Vaccine (09:45-10:15) Michael W. Washabaugh
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) David Wohlpart
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:45-10:15) David Wohlpart
Impact of Extractables and Leachables on Well Characterized Protein Products (10:45-13:25) John P. Hennessey
Emerging Analytical Technologies (13:25-15:30) John P. Hennessey
Emerging Analytical Technologies: Chairperson's Remarks (13:25-13:30) John P. Hennessey
Process and Analytical Related Issues: Specifications - The Interface between Clinical, Analytical, and Process (16:00-16:30) Timothy , Schofield
Process and Analytical Related Issues (15:30-17:00) Timothy , Schofield
November 7, 2007 Antibodies Europe: Engineering the Next Generation of Antibodies Nov (07-08) Engineering for Optimum Performance and Yield (16:15-19:15) Ping Zhong
Engineering for Optimum Performance and Yield: Antibody Optimization by AISIM Technology (17:45-18:15) Ping Zhong
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 1: Keynote Forum (09:30 -12:00) Dr. Bharatt M. Chowrira
Session 1: Embracing Cross-Border Alliances to Expand and Advance Drug Discovery Activities (10:00-10:30) Dr. Bharatt M. Chowrira
Session 4: (Part One) Anti-Infectious Drug Discovery & Development (I) (Part Two) RNAi & Gene: Applications in Drug Discovery and Therapeutics (13:30-17:05) Dr. Bharatt M. Chowrira
Session 4: RNAi-Based Therapeutics- The Promise and Challenges (15:00-15:20) Dr. Bharatt M. Chowrira
Session 9: Innovative Metabolic Diseases Drug Discovery & Development (13:30-17:05) Ruojing Yang
Session 9: RNA Interference for Target Identification and Validation (13:30-13:50) Ruojing Yang
November 1, 2007 Characterization and Comparability for Complex Biological Products Characterization & Comparability of a Recombinant HPV Vaccine Michael W. Washabaugh
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) POTASSIUM CHANNELS AND DISEASE (14:10-15:45) James Herrington
POTASSIUM CHANNELS AND DISEASE: Potassium Channels of the Pancreatic Beta-cell and Their Regulation of Insulin Secretion (15:15-15:45) James Herrington
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) DISCOVERY CHEMISTRY (08:35-12:55) H. Blair Wood
DISCOVERY CHEMISTRY: Selective PPAR gamma Modulators for the Treatment of Type 2 Diabetes (09:10-09:40) H. Blair Wood
October 16, 2007 Inaugural Kinbase Inhibitors: Moving Forward into Clinical Studies Oct (16-17) Executive Panel: Delivering Drugs for Difficult Targets (08:40-09:40) Lex Van der Ploeg, Shama Kajiji
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) OVERCOMING THE CHALLENGES: ADVANCED HDAC INHIBITORS (08:30-11:10) Thomas A. Miller
OVERCOMING THE CHALLENGES - ADVANCED HDAC INHIBITORS: Histone Deacetylase Inhibitors: Bench to Bedside (08:40-09:10) Thomas A. Miller
Roundtable Discussion Sessions - Topic: HDAC Inhibitors and Drug Selectivity Issues (07:30-08:30) Thomas A. Miller
Keynote Session: Executive Panel: Delivering Drugs for Difficult Targets(08:40-09:40) Lex Van der Ploeg, Shama Kajiji
NEXT GENERATION HDAC INHIBITORS: Structural Biology of Human Histone Deacetylase Enzymes (11:10-11:40) Andrea Carfi
NEXT GENERATION HDAC INHIBITORS (10:35-12:40) Thomas A. Miller, Andrea Carfi
NEXT GENERATION HDAC INHIBITORS: Chairperson’s Remarks (10:35-10:40) Thomas A. Miller
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies (08:30-10:40) Marc Ferrer
In vitro RNAi Screening Strategies: Genome-Wide siRNA HTS: Multi-readout and Multi-temporal Assays to Identify Physiologically Relevant Genes (09:10-09:40) Marc Ferrer
Keynote Introduction; Executive Panel: Delivering Drugs for Difficult Targets (08:40-09:40) Lex Van der Ploeg, Shama Kajiji
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) ADDRESSING THE VALIDATION BOTTLENECK: Chairperson’s Remarks (11:10-11:15) Peter DePhillips
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) CASE STUDIES OF PRACTICAL SYNTHESIS (13:30-18:30) Cheng-yi Chen
CASE STUDIES OF PRACTICAL SYNTHESIS: Catalytic, Enantioselective Synthesis of Taranabant, a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity (14:40-15:10) Cheng-yi Chen
BIOCATALYSIS FOR CHEMICAL PROCESS DEVELOPMENT (08:55-12:00) Paul N. Devine
BIOCATALYSIS FOR CHEMICAL PROCESS DEVELOPMENT: Biocatalysis in Process Research (09:00-09:30) Paul N. Devine
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) Keynote Session 2: Creating the IT Infrastructure to Enable Adaptive Clinical Development (16:00-16:45) Jerald S. Schindler
BRIDGING DISCOVERY/DEVELOPMENT AND IT (09:30-15:30) Lori Harmon, Vic Uebele
BRIDGING DISCOVERY/DEVELOPMENT AND IT: Making the Most of Limited Resources - Creation of a Merck-wide Biologics Database (11:00-11:45) Lori Harmon, Vic Uebele
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Qiuwei Xu
Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Metabolites, Mechanisms, and Pathways (13:30-14:00) Qiuwei Xu
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Metabolites, Mechanisms, and Pathways (13:30-14:00) Qiuwei Xu
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Qiuwei Xu
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.